What is the dosing regimen for ASTEPRO 0.15%?
The FDA recommended dose for ASTEPRO 0.15% is 2 sprays per nostril QD or 1 to 2 sprays per nostril BID in patients 12 years and older with SAR and 2 sprays per nostril BID in patients 12 years and older with PAR. Q: What are the most commonly reported adverse events in the 2- to 4-week SAR and PAR trials with ASTEPRO 0.15% A: The most commonly reported adverse events when ASTEPRO 0.15% was dosed 2 sprays per nostril (once or twice daily, respectively) for SAR and PAR included bitter taste (4%, 6%), nasal discomfort (4%, 3%), epistaxis (2%, 1%), and sneezing (1%, 2%).
